These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19287313)

  • 1. Sarcolemmal neuronal nitric oxide synthase defect in limb-girdle muscular dystrophy: an adverse modulating factor in the disease course?
    Fanin M; Tasca E; Nascimbeni AC; Angelini C
    J Neuropathol Exp Neurol; 2009 Apr; 68(4):383-90. PubMed ID: 19287313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle fatigue, nNOS and muscle fiber atrophy in limb girdle muscular dystrophy.
    Angelini C; Tasca E; Nascimbeni AC; Fanin M
    Acta Myol; 2014 Dec; 33(3):119-26. PubMed ID: 25873780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of sarcolemma nNOS in sarcoglycan-deficient muscle.
    Crosbie RH; Barresi R; Campbell KP
    FASEB J; 2002 Nov; 16(13):1786-91. PubMed ID: 12409321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association between dystrophin and neuronal nitric oxide synthase in muscles of progressive muscular dystrophy].
    Wang S; Shen D
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):155-7. PubMed ID: 11953148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrosative stress elicited by nNOSµ delocalization inhibits muscle force in dystrophin-null mice.
    Li D; Yue Y; Lai Y; Hakim CH; Duan D
    J Pathol; 2011 Jan; 223(1):88-98. PubMed ID: 21125668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcoglycanopathies: can muscle immunoanalysis predict the genotype?
    Klinge L; Dekomien G; Aboumousa A; Charlton R; Epplen JT; Barresi R; Bushby K; Straub V
    Neuromuscul Disord; 2008 Dec; 18(12):934-41. PubMed ID: 18996010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of neuronal nitric oxide synthase (nNOS) as a pathological marker for the diagnosis of Becker muscular dystrophy with rod domain deletions.
    Torelli S; Brown SC; Jimenez-Mallebrera C; Feng L; Muntoni F; Sewry CA
    Neuropathol Appl Neurobiol; 2004 Oct; 30(5):540-5. PubMed ID: 15488030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene transfer establishes primacy of striated vs. smooth muscle sarcoglycan complex in limb-girdle muscular dystrophy.
    Durbeej M; Sawatzki SM; Barresi R; Schmainda KM; Allamand V; Michele DE; Campbell KP
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8910-5. PubMed ID: 12851463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of sarcolemmal nNOS is common in acquired and inherited neuromuscular disorders.
    Finanger Hedderick EL; Simmers JL; Soleimani A; Andres-Mateos E; Marx R; Files DC; King L; Crawford TO; Corse AM; Cohn RD
    Neurology; 2011 Mar; 76(11):960-7. PubMed ID: 21403107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatigue and muscle atrophy in a mouse model of myasthenia gravis is paralleled by loss of sarcolemmal nNOS.
    Meinen S; Lin S; Rüegg MA; Punga AR
    PLoS One; 2012; 7(8):e44148. PubMed ID: 22952904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of sarcoglycans, vinculin-talin-integrin system and filamin2 in alpha- and gamma-sarcoglycanopathy: an immunohistochemical study.
    Anastasi G; Cutroneo G; Trimarchi F; Santoro G; Bruschetta D; Bramanti P; Pisani A; Favaloro A
    Int J Mol Med; 2004 Dec; 14(6):989-99. PubMed ID: 15547664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and localization of protein inhibitor of neuronal nitric oxide synthase in Duchenne muscular dystrophy.
    Guo Y; Petrof BJ; Hussain SN
    Muscle Nerve; 2001 Nov; 24(11):1468-75. PubMed ID: 11745948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscular dystrophy in mdx mice despite lack of neuronal nitric oxide synthase.
    Chao DS; Silvagno F; Bredt DS
    J Neurochem; 1998 Aug; 71(2):784-9. PubMed ID: 9681470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasomodulation by skeletal muscle-derived nitric oxide requires alpha-syntrophin-mediated sarcolemmal localization of neuronal Nitric oxide synthase.
    Thomas GD; Shaul PW; Yuhanna IS; Froehner SC; Adams ME
    Circ Res; 2003 Mar; 92(5):554-60. PubMed ID: 12600881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inflammatory pathology of dysferlinopathy is distinct from calpainopathy, Becker muscular dystrophy, and inflammatory myopathies.
    Becker N; Moore SA; Jones KA
    Acta Neuropathol Commun; 2022 Feb; 10(1):17. PubMed ID: 35135626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcolemma-localized nNOS is required to maintain activity after mild exercise.
    Kobayashi YM; Rader EP; Crawford RW; Iyengar NK; Thedens DR; Faulkner JA; Parikh SV; Weiss RM; Chamberlain JS; Moore SA; Campbell KP
    Nature; 2008 Nov; 456(7221):511-5. PubMed ID: 18953332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caveolin 3 suppresses phosphorylation-dependent activation of sarcolemmal nNOS.
    Ohsawa Y; Ohtsubo H; Saito Y; Nishimatsu SI; Hagiwara H; Murakami T; Nishino I; Sunada Y
    Biochem Biophys Res Commun; 2022 Nov; 628():84-90. PubMed ID: 36084555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy.
    Brenman JE; Chao DS; Xia H; Aldape K; Bredt DS
    Cell; 1995 Sep; 82(5):743-52. PubMed ID: 7545544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studying the role of dystrophin-associated proteins in influencing Becker muscular dystrophy disease severity.
    van den Bergen JC; Wokke BH; Hulsker MA; Verschuuren JJ; Aartsma-Rus AM
    Neuromuscul Disord; 2015 Mar; 25(3):231-7. PubMed ID: 25633150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-sarcoglycanopathy (LGMD 2E) in a Spanish family.
    Rivas E; Teijeira S; dos Santos MR; Porrit I; Leturcq F; Fernandez JM; Navarro C
    Acta Myol; 2004 Dec; 23(3):159-62. PubMed ID: 15938574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.